This suggests that clinical recommendations for T2DM should prioritize dual interventions for optimizing insulin sensitivity, as the metabolic flexibility needed to improve insulin action is best achieved through combined lifestyle changes. The gene discussed is INS; the disease is type 2 diabetes mellitus.